Nicholas Investment Partners, LP Dexcom Inc Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$110.31 - $140.45 $2.61 Million - $3.33 Million	-23,689 Reduced 66.87%	11,738 $1.33 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $3.12 Million - $3.83 Million	27,355 Added 338.89%	35,427 $4.91 Million
Q4 2023 Feb 07, 2024	BUY	$75.49 - $124.16 $609,355 - $1 Million	8,072 New	8,072 $1 Million
Q2 2019 Aug 09, 2019	SELL	$27.84 - $38.92 $812,844 - $1.14 Million	-29,197 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $244,966 - $333,196	8,727 Added 42.63%	29,197 $3.48 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $552,485 - $764,963	20,470 New	20,470 $2.45 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.